The gene DYRK1A could be a potential therapeutic target to treat ‘glue ear’ in people with Down syndrome, according to a new study.
The genetic cause for the most common type of hearing loss in children with Down syndrome has been identified in mice by ...
This study addresses fundamental questions surrounding otitis media effusion in Down syndrome, identifying DYRK1A as a key gene involved in the condition. The findings are compelling, highlighting ...
As a parent, it’s natural to want to track her progress, especially when it comes to height and weight. Growth charts can ...
In addition to Dollarama, another top-notch Canadian growth stock to buy now is goeasy (TSX:GSY), a stock that’s down more than 20% from its highs. For years goeasy has grown its business ...
You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...
EQB Inc (TSX:EQB) is a growth stock that took a beating recently. Here’s why it might be a good dip buy. When you’re looking for good stocks to buy, it pays to look into beaten down stocks ...
Building on the momentum of anticipated changes to U.S. crypto policy, Binance.US said it aims to restore its USD services in early 2025, according to a statement shared with Decrypt. It marks the ...
Incomes remain stagnant in rural and semi-urban areas. This impacts loan repayments. NBFC growth is expected to slow down. Companies are revising their strategies. Asset quality, especially in ...
A recent study has shown that low-dose Cold Atmospheric Plasma (CAP) treatment could effectively slow down tumor growth. The research, published in Advanced Science, suggests that CAP could be a ...
Finance minister Nirmala Sitharaman on Tuesday said that economic expansion rate in the last three years had averaged 8.3% and that the “less than expected” 5.4% growth in the September ...
What’s more, the Dutch data shows that Chinese import volume growth has collapsed, and Chinese imports in volume terms are now shrinking (looking at the y/y change in the 3-month moving average).